Mary Szela - Feb 13, 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Mary Szela
Stock symbol
TLSI
Transactions as of
Feb 13, 2024
Transactions value $
$0
Form type
4
Date filed
2/14/2024, 06:44 PM
Previous filing
Aug 15, 2023
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +84.9K +30.33% $0.00 365K Feb 13, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +289K $0.00 289K Feb 13, 2024 Common Stock 289K $9.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 13, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F2 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 13, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.